Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Merck And Co Inc Company Profile

« Back to Dashboard

Summary for Applicant: Merck And Co Inc

Drug Master File Entries: (click here to view)109
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck And Co Inc
fosaprepitant dimeglumine
POWDER;INTRAVENOUS022023-002Nov 12, 2010RXYes5,691,336<disabled>YY <disabled>
Merck And Co Inc
alendronate sodium
TABLET;ORAL020560-002Sep 29, 1995DISCNNo<disabled><disabled>
Merck And Co Inc
alendronate sodium
TABLET;ORAL020560-003Apr 25, 1997DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?